Our Sites

The BWI-CTU integrates 3 highly productive Clinical Research Sites.

All 3 sites provide top-quality clinical care and clinical research at the same facility. Our sites are in urban areas most greatly affected by the HIV epidemic, and include the largest HIV clinic in Baltimore and Washington, paired with India’s second largest HIV clinic.  The BWI-CTU optimizes patient-oriented research and access to key populations affected by the HIV epidemic for participation in clinical trials.

To learn specific details about each site, follow the links above.

Clinical Trials

A5288: MULTIOCTAVE, Management Using the Latest Technologies...

The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...

Read More

A5337: Safety and Efficacy of Sirolimus for HIV Reservoir...

When a person becomes infected with HIV the immune system (the system that helps fight infection) is weakened (partly because...

Read More

NWCS 445: Novel Biomarkers to Shorten TB Treatment

Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...

Read More

P1077FF: Formula Feeding Version of the PROMISE Study...

1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...

Read More

A5314: Effect of LDMTX on Inflammation in HIV-infected...

A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...

Read More